erlotinib - Globe Thesis

Keyword [erlotinib] Result: 1 - 20 \| Page: 1 of 8
1.	The Impact Of Human EGFR Kinase Domain Mutations On Lung Tumorigenesis And In Vivo Sensitivity To EGFR Targeted Therapies
2.	Enhancement Of Radiation Cytotoxicity By Blocking EGFR And COX-2 Pathways In A549 Human Lung Cancer Cell Line
3.	Expression Of E-cadherin In Laryngeal Squamous Cell Carcinoma And Its Relationship With Tumor Invasion And Metastases
4.	Study On Simulataneous Targeting Of EGFR And MTOR Inhibits The Growth Of Colon Carcinoma Cells
5.	Empirical Study Of Artesunate Anti-cancer Effect And Potentiating The Activity Of Erlotinib Against Non-small Cell Lung Cancer Cells
6.	Radiotherapy Combined With Targeted Therapy And Prognositic Biomarkers For Esophageal Squamous Cell Carcinoma Intraoperative Radiotherapy For Abdominal Carcinoma
7.	Regulation Of Indomethacin,Single Or In Combination With Erlotinib In The Growth Of Pancreatic Carcinoma
8.	Screening For In Vitro Antitumor Activities Of Quinazoline Compounds And Study On The Novel Mechanism Involved In The Antitumor Action Of Erlotinib
9.	Synergistic Interaction Of Pemetrexed With Gemcitabine Or Erlotinib In Different Combinations On Inducing The Apoptosis Of A549 Cell
10.	The Clinical Efficacy And Tolerability Of EGFR-TKI In Locally Advanced Or Metastatic NSCLC Patients
11.	The Effects Of Combined Administration Of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors And Cytotoxic Drugs In Different Tumor Cell Lines
12.	Radiosensitivity Enhancement By Combined Treatment Of COX-2 Inhibitor And EGFR Inhibitor On A549 Human Lung Adenocarcinoma
13.	Effects Of Gemcitabine, Pemetrexed And Erlotinib On The Proliferation Of Pancreatic Cancer BXPC-3 And PANC-1 Cells And Its Cellular Mechanism
14.	Research Of Erlotinib For Patients With Advanced NSCLC
15.	Inhibitory Effects Of Celecoxib And Erlotinib In Colorectal Cancer Cell Lines HT-29 In Vitro
16.	Efficacy Of Erlotinib And Gefitinib On Advanced Non-small Cell Lung Cancer And Analysis Of Survival Associated Factors
17.	Systematic Review Of Gefitinib And Erlotinib For Treating Non-small-cell Lung Cancer: Screening Dominant Crowd
18.	Clinical And Experimental Study On Treating Lung Cancer With Erlotinib And Fei Yiliu Heji
19.	Erlotinib Combined With Celecoxib Inhibits The Growth Of Lung Cancer A549 Cells By Simultaneously Blocking EGFR And COX-2
20.	Effectiveness Of Erlotinib As The Sennd-line Therapy In Patients With Advanced NSCLC
<<First <Prev Next> Last>> Jump to